• Username (E-mail)
  • Password
Dow 19,913 0.6%  EStoxx50 3,282 0.3%  Nikkei 18,788 -0.6%  EUR 1.0734 -0.3% 
Nasdaq 5,601 0.9%  FTSE100 7,150 0.0%  Yen 113.7880 1.0%  Oil 55.4 0.0% 
S&P500 2,280 0.7%  DAX 11,595 0.4%  GBP 1.2516 -0.1%  Gold 1,210 -0.8% 

Vertex Pharmaceuticals share [Symbol: VRTX / ISIN: US92532F1003]

Profile Vertex Pharmaceuticals Inc.

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Shareholder

Owner in %
Freefloat99.46
T. Rowe Price Associates, Inc.9.47
Fidelity Management & Research Co.9.06
Capital Research & Management Co. (World Investors)8.99
The Vanguard Group, Inc.6.29
Wellington Management Co. LLP5.82
BlackRock Fund Advisors5.14
SSgA Funds Management, Inc.4.62
Columbia Management Investment Advisers LLC3.11
JPMorgan Investment Management, Inc.3.09
ClearBridge Investments LLC2.94
Jennison Associates LLC2.09
Waddell & Reed Investment Management Co.1.63
Northern Trust Investments, Inc.1.20
Goldman Sachs Asset Management LP1.05

Address

50 Northern Avenue, 02210 Boston
Postofficebox:
Telephone: 16173416100
Fax:
Internet: http://www.vrtx.com
E-mail:

Management

Jeffrey M. Leiden MD, PhDStuart A. Arbuckle
Jeffrey A. Chodakewitz, MDDavid Matthew Altshuler MD, PhD
Joshua S. Boger, PhDMichael J. Parini
Ian F. SmithZachry Barber
Margaret G. McGlynn, MBATerrence C. Kearney, MBA
Yuchun Lee, MBAWilliam D. Young MBA, PHD
Sangeeta N. Bhatia MD, PhDBruce I. Sachs, MBA
Elaine S. UllianSimon Bedson, MBA
Michael J. LaCasciaAmit K. Sachdev
Paul M. SilvaG. Michael Palladino
Dawn KalmarMichael Partridge

Board of Directors

Add or Edit Instrument